Mango Consumption for Satiety
Recruiting in Palo Alto (17 mi)
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: San Diego State University
Disqualifiers: Smoker, Pregnant, Dietary supplements, others
No Placebo Group
Trial Summary
What is the purpose of this trial?
The objective of the study is to determine the effects of fresh mango pulp consumption on satiety and metabolic parameters in overweight/obese adults.
Do I need to stop taking my current medications for the trial?
The trial requires that you do not need any medication for metabolic disorders, so if you are taking such medications, you may not be eligible to participate.
What data supports the effectiveness of fresh mango pulp consumption for satiety?
Is mango consumption generally safe for humans?
How does fresh mango pulp consumption as a treatment for satiety differ from other treatments?
Fresh mango pulp consumption is unique because it not only promotes greater feelings of fullness compared to refined snacks like low-fat cookies, but it also helps stabilize blood sugar levels more effectively than dried mango or white bread. This makes it a natural and nutritious option for improving satiety and managing post-meal blood sugar levels.123411
Eligibility Criteria
This trial is for adults aged 18-55 with a BMI between 27 and 40, who are not pregnant, do not smoke, don't need dietary supplements or medications for metabolic disorders, and have no allergies to mango or gluten.Inclusion Criteria
Your body mass index (BMI) is between 27 and 40.
I am between 18 and 55 years old.
Exclusion Criteria
Pregnant woman
I am on medication for a metabolic disorder.
Required dietary supplement use
See 2 more
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Treatment
Participants consume 100 kcal of either mango fruit or low fat cookies daily
12 weeks
Regular visits for outcome measures at baseline, week 4, and week 12
Follow-up
Participants are monitored for safety and effectiveness after treatment
4 weeks
Treatment Details
Interventions
- Fresh Mango Pulp Consumption (Behavioural Intervention)
Trial OverviewThe study aims to see if eating fresh mango pulp affects how full people feel and their heart health-related numbers compared to having a low-fat cookie. Participants will be given either the fruit or the cookie in this research.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mango fruitExperimental Treatment1 Intervention
Subjects consume 100 kcal of mango fruit daily for 12 weeks.
Group II: Low fat cookiesActive Control1 Intervention
Subjects consume 100 kcal of low fat cookies daily for 12 weeks.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
School of Exercise and Nutritional Sciences, SDSUSan Diego, CA
Loading ...
Who Is Running the Clinical Trial?
San Diego State UniversityLead Sponsor
References
Fresh Mango Consumption Promotes Greater Satiety and Improves Postprandial Glucose and Insulin Responses in Healthy Overweight and Obese Adults. [2022]Mangos are an understudied fruit rich in fiber and polyphenols that have been linked to better metabolic outcomes and promotion of satiety. The purpose of this study was to examine the effect of mango consumption on postprandial glucose, insulin, and satiety responses. Using a randomized crossover study design, 23 overweight and obese men and women consumed 100 kcal snacks of fresh mangos or isocaloric low-fat cookies on two separate occasions. Insulin and satiety hormones were measured at baseline and 45 min post-snack consumption. Glucose was measured at baseline, 30, 60, 90, and 120 min after snack consumption. Satiety questionnaires were completed at baseline and every 20 min for 120 min post-consumption. Both mangos and low-fat cookies increased insulin, with a significantly lower increase for mangos compared with low-fat cookies at 45 min post-snack consumption (P ≤ .05). Glucose increased at 30 min for both snacks; however, the increase was significantly higher for low-fat cookie consumption (P ≤ .05). Cholecystokinin increased after mangos and low-fat cookie consumption (P ≤ .05); however, no differences were detected between the snacks. Adiponectin increased after mango consumption (P ≤ .05) but not after low-fat cookies. Mango consumption reduced hunger, anticipated food consumption and thirst, and increased feelings of fullness (P ≤ .05). Low-fat cookie consumption increased fullness for a shorter time period and did not reduce participants' desire to eat. These results suggest that relative to a refined cookie snack, mangos promote greater satiety and improve postprandial glycemic responses. Future research on long-term effects of mango consumption on food intake, weight control, and glucose homeostasis is warranted. Clinical Trial Registration number: #NCT03957928.
Effects of fresh vs dried mango consumption on satiety and postprandial glucose in healthy adults. [2023]Mango is a widely favored fruit that offers high nutritional value. Mango has been studied to examine its influence on postprandial glucose, but few studies have used fresh mango compared to dried mango to measure blood glucose and satiety after consumption. Therefore, the objective of the present study was to investigate the effects of fresh versus dried mango consumption on satiety and postprandial glucose. A crossover design was implemented where 34 healthy adults (29 females and 5 males; 25.0 ± 6.0 years; BMI 23.8 ± 4.3 kg/m2) consumed either 100 kcal of fresh mango, dried mango, or white bread on three separate occasions. Following consumption, satiety was assessed every 15 min for 90 min and blood glucose was assessed every 30 min for 90 min. Consumption of fresh mango results showed a significant increase in satiety (tendency of greater fullness (P = 0.073) and less desire to eat (P < 0.05)) in participants. Fresh mango exhibited a more efficient decrease in postprandial glucose levels (P < 0.05) compared to dried mango or white bread, and fresh mango promoted a greater stability in blood glucose. Dried mango consumption also significantly lowered postprandial glucose compared to white bread (P < 0.05). These results suggest that fresh mango consumption may be beneficial in improving satiety responses and postprandial glucose control when compared to its dried alternative or white bread. The results of the study may help guide individuals who are overweight or obese and/or have type 2 diabetes by altering their food choices that ultimately could improve their health. ClinicalTrials.gov Identifier: NCT03956602.
The effect of fruit in different forms on energy intake and satiety at a meal. [2021]Consuming whole fruit reduces ratings of satiety more than fruit juice, but little is known about the effects of different forms of fruit on subsequent energy intake. This study tested how consuming preloads of apples in different forms prior to a meal (apple, applesauce, and apple juice with and without added fiber) influences satiety and energy intake at meal. Preloads were matched for weight, energy content, energy density, and ingestion rate. Once a week for 5 weeks, 58 adults consumed one of four preloads (266 g; 125 kcal [523 kJ]), or no preload (control), followed by a test meal consumed ad libitum 15 min later. Results showed that eating apple reduced lunch energy intake (preload+test meal) by 15% (187+/-36 kcal [782+/-151 kJ]) compared to control (papplesauce>both juices>control). Overall, whole apple increased satiety more than applesauce or apple juice. Adding naturally occurring levels of fiber to juice did not enhance satiety. These results suggest that solid fruit affects satiety more than pureed fruit or juice, and that eating fruit at the start of a meal can reduce energy intake.
Mango Consumption Is Associated with Improved Nutrient Intakes, Diet Quality, and Weight-Related Health Outcomes. [2022]As nutrient-dense fruits, mangoes are commonly consumed globally and are important sources of nutrients in the diet. Nonetheless, mangoes remain relatively under-consumed in the United States. The objective of the present analysis was to examine nutrient intakes, diet quality, and health outcomes using data from NHANES 2001-2018 in children and adult mango consumers (n = 291; adults n = 449) compared with mango non-consumers (children n = 28,257; adults n = 44,574). Daily energy and nutrient intakes were adjusted for a complex sample design of NHANES using appropriate weights. Mango consumption was not associated with daily energy intake, compared with non-consumption, in both children and adults. Children consuming mangoes had a significantly lower daily intake of added sugar, sodium, total fat, and a higher intake of dietary fiber, magnesium, potassium, total choline, vitamin C, and vitamin D, compared with non-consumers. In adults, mango consumers had significantly higher daily intakes of dietary fiber, magnesium, potassium, folate, vitamin A, vitamin C, and vitamin E and significantly lower intakes of added sugar and cholesterol, compared with non-consumers. Mango consumption was also associated with a better diet quality vs. mango non-consumers (p < 0.0001). Mango consumption in adolescents was associated with lower BMI z-scores, compared with non-consumption. In adults, BMI scores, waist circumference, and body weight were significantly lower only in male mango consumers when compared with mango non-consumers. The current results support that mango consumption is associated with improved nutrient intakes, diet quality, and certain health outcomes. Thus, dietary strategies that aim to increase mango consumption in the American population should be evaluated as part of future dietary guidance.
Influences of harvest date and location on the levels of beta-carotene, ascorbic acid, total phenols, the in vitro antioxidant capacity, and phenolic profiles of five commercial varieties of mango (Mangifera indica L.). [2013]Mango (Mangifera indica L.) is a tropical fruit grown worldwide with excellent nutritional value and widely attributed health-promoting properties. Extensive studies have been made of the high concentrations of phenolic antioxidants in mango peels, seeds, and leaves, yet less is known about the phenolic antioxidants of mango fruit pulp. Five varieties of mangoes from four countries were evaluated with multiple harvests over 1 year to compare the beta-carotene, ascorbic acid, and total phenolic contents and antioxidant capacities of the fruit pulp and to compare the phenolic profiles of the individual varieties. To minimize ripeness variability, only soft fruit (0.5-1 N compression) with a minimum of 10% soluble solids were used for these measurements. Ascorbic acid ranged from 11 to 134 mg/100 g of pulp puree, and beta-carotene varied from 5 to 30 mg/kg among the five varieties. Total phenolic content ranged from 19.5 to 166.7 mg of gallic acid equivalents (GAE)/100 g of puree. The varieties Tommy Atkins, Kent, Keitt, and Haden had similar total phenolic contents, averaging 31.2+/-7.8 mg GAE/100 g of puree, whereas the variety Ataulfo contained substantially higher values. Similar trends were observed in the DPPH radical scavenging activities among the five varieties. In contrast, the country of origin and harvest dates had far less influence on these parameters. Ataulfo mangoes contained significantly higher amounts of mangiferin and ellagic acid than the other four varieties. Large fruit-to-fruit variations in the concentrations of these compounds occurred within sets of mangoes of the same cultivar with the same harvest location and date.
Estimated daily intake and safety of FD&C food-colour additives in the US population. [2018]A refined exposure assessment was undertaken to calculate the estimated daily intake (EDI) of the seven FD&C straight-colour additives and five FD&C colour lakes ('synthetic' food colours) approved in the United States. The EDIs were calculated for the US population as a whole and specific age groups, including children aged 2-5 and 6-12 years, adolescents aged 13-18 years, and adults aged 19 or more y. Actual use data were collected from an industry survey of companies that are users of these colour additives in a variety of products, with additional input from food colour manufacturers. Food-consumption data were obtained from the National Health and Nutrition Examination Survey (NHANES). The assessment was further refined by adjusting the intake to more realistic scenarios based on the fraction of products containing colour within specific food categories using data provided by the Mintel International Group Ltd. The results of the analysis indicate that (1) the use levels reported by the industry are consistent with the concentrations measured analytically by the US Food and Drug Administration; and (2) exposure to food-colour additives in the United States by average and high-intake consumers is well below the acceptable daily intake (ADI) of each colour additive as published by the Joint WHO/FAO Committee on Food Additives (JECFA) and allows wide margins of safety. It is concluded that food colour use as currently practised in the United States is safe and does not result in excessive exposure to the population, even at conservative ranges of food consumption and levels of use.
Safety impact--the risk/benefits of functional foods. [2021]It is amazing to see how much the approach of the food risk analysis evolved in the recent years. For half a century and the birth of the risk assessment methodology in the food domain, only no appreciable health risk was considered acceptable by the manager. This is the vocabulary used in the case of a voluntary, deliberated human action, as the use of food additives (definition of ADI). In the case of risks not resulting from such an action, as that of the presence of contaminants, the risk assessor allocates provisional tolerable daily, weekly or monthly intake that are the basis for regulation. This vocabulary is in agreement with the objective which consists in approaching closer possible of the zero risk which is the wish of a majority of the consumers. Some years ago, the risk managers insisted to obtain from the assessors as often as possible a quantitative risk evaluation. More recently even, the managers would like to decide on the basis of a balance of risk and benefit acceptable for management purposes. Finally, they hope that general principles and tools will be available for conducting a quantitative risk-benefit analysis for foods and food ingredients. What is possible in the case of functional foods (FF)? Based on the definition of FF proposed in the programme FUFOSE, one has to distinguish between different situations in order to assess the risk: that of a micro-, that of a macro-component or that of a whole food. These situations have been clearly described in the document resulting from FOSIE. The standardized methodology relevant to assess micro-components is not well adapted to the assessment of whole food. Concepts of substantial equivalence and of history of safe use could be useful tools in this case. However, quantitative risk assessment remains a very difficult exercise. If a process for the assessment of health benefit of FF has been proposed as an outcome of the PASSCLAIM action, the quantification of this benefit needs adequate tools. An EFSA scientific colloquium on "Risk-Benefit Analysis of Foods" organized in July 2006 concluded that the risk-benefit analysis should mirror the current risk analysis paradigm and that its assessment should be performed with common scales. Disability adjusted life years (DALYs) or quality adjusted life years (QUALYs) have been proposed as some of these common scales. However, the meeting "concluded that the data available to undertake a quantitative risk-benefit assessment may be too scarce". Because it was considered that it was premature to formulate guidelines on good risk-benefit analysis practice and it is now time to "learning by doing", a reference to the upcoming ILSI Europe project BRAFO was done. All these aspects are discussed, in particular in relation to the specific case of FF.
Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. [2019]There is a growing interest by both consumers and industry for the development of food products with 'functional' properties, or health benefits. These products may take the form of dietary supplements or of foods. The health benefits are given by particular ingredients, and in many cases these are derived from botanicals. The variety of plants providing these functions is large, ranging from staple food sources such as cereals, fruits and vegetables, to herbals as used in traditional medicine. The food or ingredient conferring health properties may consist of the plants themselves, extracts thereof, or more purified components. The scientific literature is abundant with articles not only on the beneficial properties, but also on possible adverse health effects of plants and their components. The present report discusses the data required to determine the safe use of these types of ingredients, and provides advice on the development of risk assessment strategies consistent with due diligence under existing food regulations. Product specifications, composition and characterisation of standardised and authentic materials, documented history of use and comparison to existing products (taking into account the effect of industrial processing), description of the intended use and consequent exposure are highlighted as key background information on which to base a risk evaluation. The extent of experimental investigation required, such as in vitro, animal, and/or human studies, depends on the adequacy of this information. A decision tree is presented as an aid to determine the extent of data requirements based on product comparison. The ultimate safety in use depends on the establishment of an adequate safety margin between expected exposure and identified potential hazards. Health hazards may arise from inherent toxicities or contaminants of the plant materials, including the mechanism of the intended beneficial effect. A lower safety margin may therefore be expected than for food ingredients or additives where no physiological effects are intended. In rare cases, post launch monitoring programmes may be envisaged to confirm expected exposures and adequacy of the safety margin. This guidance document was elaborated by an expert group of the Natural Toxin Task Force of the European Branch of the International Life Sciences Institute--ILSI Europe and discussed with a wider audience of scientists at a workshop held on 13-15 May 2002 in Marseille, France.
Safety of dried aerial parts of Hoodia parviflora as a novel food pursuant to Regulation (EC) No 258/97. [2023]Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on the dried aerial parts of Hoodia parviflora as a novel food (NF) submitted pursuant to Regulation (EC) No 258/97. The information provided on the composition, the specifications, the production process, the batch-to-batch variability and the stability of the NF is sufficient and does not raise safety concerns. The applicant intends to use the NF in a number of energy-reduced/sugar-free/no-added-sugar foods in quantities of up to 15 mg per serving. The applicant also proposes to provide the NF as a food supplement. The target population proposed by the applicant is adults. The highest intake estimates were found in the group of elderly (≥ 65 years) individuals, with a high intake of 1.0 mg/kg body weight (bw) per day. One 90-day toxicity study in rodents was provided from which a benchmark dose lower confidence limit (BMDL 05) of 53.5 mg/kg bw per day was derived for effects of the NF on bodyweight. The Panel concludes that the addition of the NF to foods as a food ingredient at the uses and use levels as proposed by the applicant would exceed intake levels considered safe in humans. The Panel considers that the NF is safe to be used as a food supplement at a maximum dose of 9.4 mg/day. The target population is adults.
Estimate of the theoretical maximum daily intake of Sunset Yellow FCF by the Brazilian population. [2019]This study estimated the theoretical maximum daily intake (TMDI) of Sunset Yellow (SY) synthetic food dye by the Brazilian population through food consumption data from the Household Budget Survey (HBS) of the Brazilian Institute of Geography and Statistics (IBGE, 2008/09). The study covered the population in urban and rural areas in the five regions of the country, and from different age groups, in order to verify if it were possible to exceed the acceptable daily intake (ADI) of SY, which is 4.0 mg kg-1 body weight. This was assessed by cross-checking food products containing this dye from the largest supermarket chains in Brazil with data from the HBS-IBGE 2008/09. These data showed that the average consumption of SY per capita did not exceed the ADI in any of the aforementioned population groups. However, when considering food consumption in urban and rural areas (279 and 260 mg of SY day-1), in the five regions of the country (260-338 mg of SY day-1), and for adolescents (332 mg SY day-1), it is noted that part of the population could be exceeding the recommended ADI, which may pose health risks. Although it is unlikely that individuals will exceed the SY ADI, this may occur in some cases, especially for younger people.
[In vitro and in vivo effects of mango pulp (Mangifera indica cv. Azucar) in colon carcinogenesis]. [2016]Mango pulp contains ascorbic acid, carotenoids, polyphenols, terpenoids and fiber which are healthy and could protect against colon cancer. The aim of this study was to evaluate the antiproliferative and preventive capacity of an aqueous extract of Mangifera indica cv. Azúcar on a human colon adenocarcinoma cell line (SW480) and in a rodent model of colorectal cancer, respectively. The content of total phenolics, flavonoids and carotenoids were also analyzed in the extract. SW480 cell growth was inhibited in a dose and time dependent manner by 22.3% after a 72h exposure to the extract (200 µg/ mL). Colon carcinogenesis was initiated in Balb/c mice by two intra-peritoneal injections of azoxymethane (AOM) at the third and fourth week of giving mango in drinking water (0.3%, 0.6%, 1.25%). After 10 weeks of treatment, in the colon of mice receiving 0.3% mango, aberrant crypt foci formation was inhibited more than 60% (p=0,05) and the inhibition was dose-dependent when compared with controls receiving water. These results show that mango pulp, a natural food, non toxic, part of human being diet, contains bioactive compounds able to reduce growth of tumor cells and to prevent the appearance of precancerous lesions in colon during carcinogenesis initiation.